A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK-3475) + INCB Combinations in Advanced Solid Tumors

January 27, 2018
https://clinicaltrials.gov/ct2/show/NCT02646748
Solid Tumors
Principal Investigator: Ding Wang, MD, Ding Wang, MD
Advanced Solid Tumors
Open
(313)916-1784